Get Clarity Foaming Acne Cleanser

Sulfur


The Honest Company, Inc
Human Otc Drug
NDC 69366-413
Get Clarity Foaming Acne Cleanser also known as Sulfur is a human otc drug labeled by 'The Honest Company, Inc'. National Drug Code (NDC) number for Get Clarity Foaming Acne Cleanser is 69366-413. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Get Clarity Foaming Acne Cleanser drug includes Sulfur - 3.3 g/100mL . The currest status of Get Clarity Foaming Acne Cleanser drug is Active.

Drug Information:

Drug NDC: 69366-413
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Get Clarity Foaming Acne Cleanser
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Sulfur
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: The Honest Company, Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:SULFUR - 3.3 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 May, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 08 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333D
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:The Honest Company, Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:2599924
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0810022917633
UPC stands for Universal Product Code.
UNII:70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69366-413-301 TUBE in 1 CARTON (69366-413-30) / 118.2 mL in 1 TUBE01 May, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose acne treatment

Product Elements:

Get clarity foaming acne cleanser sulfur sulfur sulfur lactic acid sodium cocoyl glycinate sodium benzoate water cocamidopropyl hydroxysultaine bentonite sodium laurylglucosides hydroxypropylsulfonate glycerin disodium cocoyl glutamate malic acid, l- sodium chloride acacia apple xanthan gum trisodium ethylenediamine disuccinate silicon dioxide glutamic acid caprylyl glycol caprylhydroxamic acid sodium cocoyl isethionate coconut acid anhydrous citric acid glycolic acid

Indications and Usage:

Use • for the treatment of acne.

Warnings:

Warnings for external use only. when using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time • avoid contact with eyes. if contact occurs, rinse thoroughly with water • apply only to areas with acne. do not use on • broken skin • large areas of the skin keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.

Do Not Use:

Warnings for external use only. when using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time • avoid contact with eyes. if contact occurs, rinse thoroughly with water • apply only to areas with acne. do not use on • broken skin • large areas of the skin keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.

When Using:

When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time • avoid contact with eyes. if contact occurs, rinse thoroughly with water • apply only to areas with acne.

Dosage and Administration:

Directions • apply a small amount to wet face and work product into a lather. massage onto face avoiding eye area. rinse thoroughly with water and pat dry. use morning and night. • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Package Label Principal Display Panel:

Honest ® get clarity foaming acne cleanser clear the way colloidal sulfer + 4 ahas (malic, glycolic, lactic and citric acid) oily 4 fl. oz. / 118.2 ml 888-862-8818 ©2022 dist. by the honest company, inc. los angeles, ca 90094 made in usa from us and imported materials label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.